Nihon Kohden, a global leader in neurodiagnostic, patient, monitoring and ventilation, today announced it is expanding the ...

LivaNova has published 12-month data supporting its proximal hypoglossal nerve stimulation (pHGNS) system for sleep apnea.

RMD's growth strategy, rising device demand and solid finances support momentum, but macro pressures and stiff competition could test its outlook.

ProSomnus Sleep Technologies ("the Company"), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy® and pioneer in Smart Sleep Medicine, today ...

ProSomnus Sleep Technologies ("the Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy® and pioneer in ...

Obstructive sleep apnea syndrome (OSAS) represents one of the most prevalent sleep-related breathing disorders, affecting approximately 50% of men and 23% of women aged 40 years or older when defined ...

Welcome to Sleep Better Week on the Strategist, where we’re helping you find everything you need to get your best rest — from testing the most comfortable mattresses to asking nosy questions about ...

CPAP machines are gaining popularity due to increased public discussion and awareness of sleep apnea. Affordable at-home sleep tests are now available, making diagnosis more accessible than ...

At-home sleep tests offer a convenient way to diagnose sleep apnea without visiting a lab. CPAP machines are a highly effective, life-changing treatment for those with sleep apnea. Modern CPAP ...

Millions of people in the U.S. have sleep apnea, most of whom aren’t getting treated for it. But a simple daily pill of an old drug just might help people with the condition, recent trial data shows.

More than a century after sleep apnea was first described in literature, and decades after it was first recognized as a clinical disorder, treatment finally caught up. In 1981, Australian physician ...